|
|
| | Klotho-derived peptide 6 Basic information |
| Product Name: | Klotho-derived peptide 6 | | Synonyms: | Klotho-derived peptide 6;L-Histidine, L-glutaminyl-L-prolyl-L-valyl-L-valyl-L-threonyl-L-leucyl-L-tyrosyl-L-histidyl-L-tryptophyl-L-α-aspartyl-L-leucyl-L-prolyl-L-glutaminyl-L-arginyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-alanyl-L-tyrosylglycylglycyl-L-tryptophyl-L-alanyl-L-asparaginyl-L-arginyl-L-alanyl-L-leucyl-L-alanyl-L-α-aspartyl- | | CAS: | 2102414-23-1 | | MF: | C159H232N46O44 | | MW: | 3491.83 | | EINECS: | | | Product Categories: | | | Mol File: | 2102414-23-1.mol |  |
| | Klotho-derived peptide 6 Chemical Properties |
| density | 1.517±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) |
| | Klotho-derived peptide 6 Usage And Synthesis |
| Uses | KP-6, a polypeptide, is a Wnt/β-catenin signal inhibitor. KP-6 inhibits TGF-β and blocks rush fibrosis signal path crucial in vivo. KP-6 suppresses Renal tissues damage and renal fibrosis, and reverse the course of disease of chronic kidney disease (CKD)[1]. | | References | [1] Youhua Liu, et al. Purposes of the micromolecule polypeptide KP 6 in the medicine for preparing treatment CKD. CN106822865A. |
| | Klotho-derived peptide 6 Preparation Products And Raw materials |
|